In December 2013, the research department at Whitman-Walker Health was excited to become the newest US site in the AIDS Clinical Trials Group (ACTG). Funded under NIH’s Department of AIDS, the ACTG was established in 1987 and has grown to be one of the largest HIV trial networks in the world. With a focus for finding the best treatments for HIV and its associated conditions, the ACTG has set the standards for HIV care.
As an ACTG site, we have the opportunity to be a part of groundbreaking research that brings us to the forefront of combating HIV, with hopes of finding a cure. WWH is now participating in research studies that will help bring new therapies to our patients with HIV, including treatments for common co-infections, such as Hepatitis C (HCV). Additionally, as people live increasingly longer with HIV, studies are investigating long-term concerns such as heart and brain health.
For information about open ACTG trials, please visit our Currently Enrolling page.